Ewa Zbrojkiewicz

ORCID: 0000-0003-0161-9377
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Cardiac Ischemia and Reperfusion
  • Transplantation: Methods and Outcomes
  • Agriculture, Plant Science, Crop Management
  • Mycotoxins in Agriculture and Food
  • Sustainable Development and Environmental Management
  • Public health and occupational medicine
  • Nutrition and Health Studies
  • Potato Plant Research
  • Nutrition and Health in Aging

Medical University of Silesia
2016-2020

Wojewódzki Szpital Specjalistyczny nr 4 w Bytomiu
2019

Górnośląskie Centrum Medyczne
2016

We investigated whether the additional determination of ceruloplasmin (Cp) levels could improve prognostic value N-terminal pro-B-type natriuretic peptide (NT-proBNP) in heart failure (HF) patients a 1-year follow-up. Cp and NT-proBNP clinical laboratory parameters were assessed simultaneously at baseline 741 HF considered as possible transplant recipients. The primary endpoint (EP) was composite all-cause death (non-transplant patients) or transplantation during one year Using cut-off 35.9...

10.3390/jcm9010137 article EN Journal of Clinical Medicine 2020-01-03

Abstract Background The catabolic predominance in acute heart failure (HF) leads to significant weight loss. low body before HF (preHF) and the loss during its natural course, both are risk factors of sarcopenia worse clinical outcome HF. Modern therapy can inhibit or even reverse catabolism resulting oedema-free gain. It is unknown if therapy-induced gain protect against appendicular skeletal muscle mass (ASM) – key prerequisite sarcopenia. Aims We intended assess whether protects ASM....

10.1093/eurheartj/ehz746.0930 article EN European Heart Journal 2019-10-01

Heart failure is a complex clinical syndrome with dominating signs and symptoms coming from organ congestion. The use of diuretics fundamental treatment. In acute phase heart usually loop given intravenously are applied. Poland the furosemide torasemide most widely used to fight These drugs have common mechanism diuretic action but vary significantly in many other aspects. Their unique features potentially clinically useful. patients treated excessive amount fluid interstitial compartment...

10.24292/01.mf.0319.1 article EN Medycyna Faktów 2019-09-30
Coming Soon ...